Our research examines the potential of machine learning models to predict health technology assessment (HTA) outcomes, offering insights into improved decision-making and strategy development for pharmaceutical companies.
Presented at ISPOR EU 2024, Barcelona, Spain.
Please click here to download the poster. Don’t forget to subscribe to our newsletter below for the latest company updates, recently published HTA guidance, industry insights, and more!